Elsbet J Pieterman Selected Research

Elsbet J Pieterman Research Topics

Disease

11	Atherosclerosis 01/2023 - 01/2013
7	Inflammation (Inflammations) 04/2023 - 08/2017
4	Insulin Resistance 11/2020 - 01/2011
3	Fibrosis (Cirrhosis) 04/2023 - 02/2020
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2023 - 01/2019
2	Non-alcoholic Fatty Liver Disease 04/2023 - 02/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2023 - 11/2022
2	Dyslipidemias (Dyslipidemia) 01/2023 - 01/2019
2	Hyperlipidemias (Hyperlipidemia) 01/2020 - 01/2019
2	Coronary Disease (Coronary Heart Disease) 08/2017 - 11/2014
2	Body Weight (Weight, Body) 11/2015 - 05/2013
1	Alcoholic Fatty Liver 04/2023
1	Obesity 01/2023
1	Hypercholesterolemia 11/2022
1	Fatty Liver 11/2020
1	Hypertrophy 02/2020
1	Diabetes Complications 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Atherosclerotic Plaque (Atheroma) 01/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018
1	Hyperglycemia 05/2013
1	Weight Gain 05/2013
1	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2013

Drug/Important Bio-Agent (IBA)

12	Apolipoproteins E (ApoE)IBA 04/2023 - 01/2013
9	CholesterolIBA 04/2023 - 01/2013
8	LipidsIBA 01/2023 - 05/2013
4	Atorvastatin (Lipitor)FDA Link 04/2023 - 10/2014
4	Glucose (Dextrose)FDA LinkGeneric 02/2020 - 01/2011
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2023 - 10/2014
3	oxidized low density lipoproteinIBA 11/2022 - 11/2014
3	LDL CholesterolIBA 08/2017 - 11/2014
2	Eicosapentaenoic AcidIBA 11/2020 - 02/2020
2	icosabutateIBA 11/2020 - 02/2020
2	HDL CholesterolIBA 11/2015 - 01/2013
2	Insulin (Novolin)FDA Link 05/2013 - 01/2011
1	InflammasomesIBA 04/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023
1	FatsIBA 01/2023
1	Mineral Oil (Liquid Paraffin)FDA LinkGeneric 06/2021
1	Pravastatin (Pravachol)FDA LinkGeneric 06/2021
1	Plasminogen Activator Inhibitor 1IBA 11/2020
1	NitritesIBA 11/2020
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2020
1	Biomarkers (Surrogate Marker)IBA 11/2020
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2020
1	E-SelectinIBA 11/2020
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 11/2020
1	Angiopoietin-2IBA 11/2020
1	Syndecan-1 (Syndecan 1)IBA 11/2020
1	Arachidonic Acid (Vitamin F)IBA 11/2020
1	obeticholic acidIBA 11/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2020
1	Islet Amyloid PolypeptideIBA 11/2020
1	FructoseIBA 11/2020
1	Rosiglitazone (Avandia)FDA Link 02/2020
1	Fenofibrate (CiL)FDA LinkGeneric 02/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2020
1	Pioglitazone (Actos)FDA Link 02/2020
1	Lipoproteins (Lipoprotein)IBA 01/2020
1	Apolipoproteins B (ApoB)IBA 01/2020
1	AntibodiesIBA 01/2019
1	OSM-LIF ReceptorsIBA 01/2019
1	Oncostatin MIBA 01/2019
1	GlucokinaseIBA 01/2019
1	nilotinib FDA Link 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	ponatinibIBA 01/2018
1	Proprotein Convertase 9IBA 08/2017
1	LDL Receptors (LDL Receptor)IBA 08/2017
1	AT04A vaccineIBA 08/2017
1	VaccinesIBA 08/2017
1	anacetrapibIBA 11/2015
1	Cholesterol Ester Transfer ProteinsIBA 11/2015
1	alirocumabIBA 10/2014
1	Blood Glucose (Blood Sugar)IBA 05/2013
1	Nonesterified Fatty Acids (NEFA)IBA 05/2013
1	Triglycerides (Triacylglycerol)IBA 05/2013
1	cholebine (colestilan)IBA 05/2013
1	Bile Acids and Salts (Bile Acids)IBA 05/2013
1	Simvastatin (Zocor)FDA LinkGeneric 01/2013
1	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2013
1	CNTO 530IBA 01/2011

Therapy/Procedure

1	Therapeutics 11/2022
1	Oral Administration 06/2021